ArticleBlood cancer journal2024

Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease.

Jialing Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.